Safety and efficacy of intensive systolic blood pressure lowering after successful endovascular therapy: a post hoc analysis of the BP TARGET trial.
Mohammad AnadaniBenjamin MaierSimon EscalardJulien LabreucheAdam H de HavenonCandice SabbenBertrand LapergueEva A MistryBenjamin GoryAlejandro M SpiottaSébastien RichardIgor SibonJean-Philippe DesillesRaphael BlancMichel PiotinMichael Mazighinull nullPublished in: Journal of neurointerventional surgery (2022)
The effect of SBP lowering treatment was not modified by age, location of occlusion history of hypertension, intravenous thrombolysis, and admission SBP. Diabetes modified the effect of intensive SBP lowering treatment, and there was a trend towards benefit from intensive SBP treatment in diabetic patients. This finding is hypothesis generating and requires further validation.